These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6376165)

  • 1. Inhibitory activity and resistance to hydrolysis by beta-lactamases of some (D,L)-7-(alpha-fluoroacylamino)cephalosporins.
    Somma S; Malabarba A; Gastaldo L; Cavalleri B
    Farmaco Sci; 1984 May; 39(5):463-72. PubMed ID: 6376165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cefdinir with beta-lactamases.
    Labia R; Morand A
    Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
    Richmond MH
    Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antipseudomonal cephalosporins.
    Watanabe NA
    J Chemother; 1996 Feb; 8 Suppl 2():48-56. PubMed ID: 8738846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Lactamase stability of some cephalosporins.
    Coppi G
    Ital J Biochem; 1984; 33(4):280A-285A. PubMed ID: 6439674
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Moxalactam: an inactivator of beta-lactamases].
    Labia R
    Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-quantification of a microbiological method using beta-lactamases in detecting the hydrolysis of beta-lactam antibiotics.
    Labia R; Guionie M
    Ann Microbiol (Paris); 1981; 132B(2):257-65. PubMed ID: 7034613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of the substrate specificity of the crude endogenous beta-lactamases of gram-negative bacteria].
    Bibikova MV; Ivanitskaia LP; Nikishina VG; Kuznetsova SM
    Antibiotiki; 1983 Aug; 28(8):566-73. PubMed ID: 6416154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophotometric investigations on the influence of cephradine and related cephalosporins on the growth of beta-lactamase-producing staphylococi.
    Breuer A; Starke B
    Arzneimittelforschung; 1978; 28(8):1327-30. PubMed ID: 313798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.